Early tacrolimus + prednisolone + nintedanib therapy markedly improved the forced vital capacity decline slope from –20.9% to +11.2% per year in untreated PPF. Initiating combination therapy with ...

The prevalence of type 2 diabetes in patients with autoimmune liver disease was 27.6%. Type 2 diabetes seems to reduce the risk of primary sclerosing cholangitis (PSC), and primary biliary cholangitis ...

Three of the 4 patients with hereditary transthyretin amyloidosis (ATTR) and a negative bone scintigraphy had cardiac carbon-11-labeled Pittsburgh compound B uptake. Cardiomyopathy could be detected ...

Prompt discontinuation of the suspected drug is critical for recovery. Drug-induced immune hemolytic anemia (DIIHA) should be investigated in suspected cases of warm autoimmune hemolytic anemia (warm ...

Key outcomes included high ILD prevalence, postmyopathic PPF in 13.5% of the cohort, higher rates of rapidly progressive ILD and transplantation in postmyopathic PPF, greater rituximab use in PPF, and ...

Two serious adverse events occurred, both of which resolved fully, and no deaths or life-threatening adverse events were reported. Prolonged treatment with tamoxifen was well tolerated in boys with ...

Combining ETAA1 and ATR improved discrimination between patients and controls, achieving an area under the curve of 0.822 with 74% sensitivity and 72% specificity. Because overexpression of the 3 ...

Insulin-like growth factor-binding protein 4 protects biliary cells from cellular injury induced by bile salts and promotes the proliferation of biliary cells in PBC. Insulin-like growth ...

Safety findings in a historically excluded CNS lymphoma population support expanded clinical use of axi-cel in eligible patients with high unmet need. The US Food and Drug Administration (FDA) ...

Between 2001 to 2011, annual age-adjusted incidence increased from 0.55/100,000 to 0.78/100,000, demonstrating an increasing trend with age. Incidence peaks in individuals over 70 years of age ...

The risk for major adverse cardiovascular events is a recognized, important complication reported among patients with ANCA-associated vasculitis. In patients with antineutrophil cytoplasmic antibody ...

The updated AABB/ICTMG guideline hopes to decrease excessive platelet transfusions. The adoption of an updated, more restrictive 2025 Association for the Advancement ...